Psoriasis Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
出 版 商：TBRC
出版日期：2020/09/09
頁 數：200頁
文件格式：PDF
價 格：
USD 4,000 (Single-User License)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
Psoriasis Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global psoriasis drugs market as it emerges from the Covid 19 shut down.
Reasons to Purchase
‧ Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
‧ Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Identify growth segments for investment.
‧ Outperform competitors using forecast data and the drivers and trends shaping the market.
‧ Understand customers based on the latest market research findings.
‧ Benchmark performance against key competitors.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the psoriasis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Psoriasis Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
‧ The Market Characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered: 1) By Drug class: Interleukin Inhibitors; Corticosteroids; Anti-Inflammatory; Tumor Necrosis Factor Inhibitor
2) By Distribution Channel: Hospitals; Retail Pharmacies; E-Commerce
3) By Drug Types: Small molecules; Biologics
4) By Route Of Administration: Oral; Tropical; Injectable
5) By Disease Indication: Plaque Psoriasis; Nail Psoriasis; Guttate Psoriasis; Pustular Psoriasis; Erythrodermic Psoriasis
Companies Mentioned: AbbVie Inc.; Pfizer Inc.; Novartis; Eli Lilly and Company.; Celgene Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
‧ Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
‧ Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Identify growth segments for investment.
‧ Outperform competitors using forecast data and the drivers and trends shaping the market.
‧ Understand customers based on the latest market research findings.
‧ Benchmark performance against key competitors.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the psoriasis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Psoriasis Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
‧ The Market Characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered: 1) By Drug class: Interleukin Inhibitors; Corticosteroids; Anti-Inflammatory; Tumor Necrosis Factor Inhibitor
2) By Distribution Channel: Hospitals; Retail Pharmacies; E-Commerce
3) By Drug Types: Small molecules; Biologics
4) By Route Of Administration: Oral; Tropical; Injectable
5) By Disease Indication: Plaque Psoriasis; Nail Psoriasis; Guttate Psoriasis; Pustular Psoriasis; Erythrodermic Psoriasis
Companies Mentioned: AbbVie Inc.; Pfizer Inc.; Novartis; Eli Lilly and Company.; Celgene Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Executive Summary
2. Psoriasis Drugs Market Characteristics
3. Psoriasis Drugs Market Size And Growth
3.1. Global Psoriasis Drugs Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Psoriasis Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Psoriasis Drugs Market Segmentation
4.1. Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Interleukin Inhibitors
Corticosteroids
Anti-Inflammatory
Tumor Necrosis Factor Inhibitor
4.2. Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Hospitals
Retail Pharmacies
E-commerce
4.3. Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Small Molecules
Biologics
4.4. Global Psoriasis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Oral
Tropical
Injectable
4.5. Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Plaque Psoriasis
Nail Psoriasis
Guttate Psoriasis
Pustular Psoriasis
Erythrodermic Psoriasis
5. Psoriasis Drugs Market Regional And Country Analysis
5.1. Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Psoriasis Drugs Market
6.1. Asia-Pacific Psoriasis Drugs Market Overview
6.2. Asia-Pacific Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Psoriasis Drugs Market
7.1. China Psoriasis Drugs Market Overview
7.2. China Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Psoriasis Drugs Market
8.1. India Psoriasis Drugs Market Overview
8.2. India Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Psoriasis Drugs Market
9.1. Japan Psoriasis Drugs Market Overview
9.2. Japan Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Psoriasis Drugs Market
10.1. Australia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Psoriasis Drugs Market
11.1. Indonesia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Psoriasis Drugs Market
12.1. South Korea Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Psoriasis Drugs Market
13.1. Western Europe Psoriasis Drugs Market Overview
13.2. Western Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Psoriasis Drugs Market
14.1. UK Psoriasis Drugs Market Overview
14.2. UK Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Psoriasis Drugs Market
15.1. Germany Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Psoriasis Drugs Market
16.4. France Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Psoriasis Drugs Market
17.1. Eastern Europe Psoriasis Drugs Market Overview
17.2. Eastern Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Psoriasis Drugs Market
18.1. Russia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Psoriasis Drugs Market
19.1. North America Psoriasis Drugs Market Overview
19.2. North America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Psoriasis Drugs Market
20.1. USA Psoriasis Drugs Market Overview
20.2. USA Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Psoriasis Drugs Market
21.1. South America Psoriasis Drugs Market Overview
21.2. South America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Psoriasis Drugs Market
22.1. Brazil Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Psoriasis Drugs Market
23.1. Middle East Psoriasis Drugs Market Overview
23.2. Middle East Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Psoriasis Drugs Market
24.1. Africa Psoriasis Drugs Market Overview
24.2. Africa Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Psoriasis Drugs Market Competitive Landscape And Company Profiles
25.1. Psoriasis Drugs Market Competitive Landscape
25.2. Psoriasis Drugs Market Company Profiles
25.2.1. AbbVie Inc.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Pfizer Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Novartis
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Eli Lilly and Company.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Celgene Corporation
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Psoriasis Drugs Market
27. Psoriasis Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Psoriasis Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer
2. Psoriasis Drugs Market Characteristics
3. Psoriasis Drugs Market Size And Growth
3.1. Global Psoriasis Drugs Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Psoriasis Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Psoriasis Drugs Market Segmentation
4.1. Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Interleukin Inhibitors
Corticosteroids
Anti-Inflammatory
Tumor Necrosis Factor Inhibitor
4.2. Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Hospitals
Retail Pharmacies
E-commerce
4.3. Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Small Molecules
Biologics
4.4. Global Psoriasis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Oral
Tropical
Injectable
4.5. Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Plaque Psoriasis
Nail Psoriasis
Guttate Psoriasis
Pustular Psoriasis
Erythrodermic Psoriasis
5. Psoriasis Drugs Market Regional And Country Analysis
5.1. Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Psoriasis Drugs Market
6.1. Asia-Pacific Psoriasis Drugs Market Overview
6.2. Asia-Pacific Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Psoriasis Drugs Market
7.1. China Psoriasis Drugs Market Overview
7.2. China Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Psoriasis Drugs Market
8.1. India Psoriasis Drugs Market Overview
8.2. India Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Psoriasis Drugs Market
9.1. Japan Psoriasis Drugs Market Overview
9.2. Japan Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Psoriasis Drugs Market
10.1. Australia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Psoriasis Drugs Market
11.1. Indonesia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Psoriasis Drugs Market
12.1. South Korea Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Psoriasis Drugs Market
13.1. Western Europe Psoriasis Drugs Market Overview
13.2. Western Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Psoriasis Drugs Market
14.1. UK Psoriasis Drugs Market Overview
14.2. UK Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Psoriasis Drugs Market
15.1. Germany Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Psoriasis Drugs Market
16.4. France Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Psoriasis Drugs Market
17.1. Eastern Europe Psoriasis Drugs Market Overview
17.2. Eastern Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Psoriasis Drugs Market
18.1. Russia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Psoriasis Drugs Market
19.1. North America Psoriasis Drugs Market Overview
19.2. North America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Psoriasis Drugs Market
20.1. USA Psoriasis Drugs Market Overview
20.2. USA Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Psoriasis Drugs Market
21.1. South America Psoriasis Drugs Market Overview
21.2. South America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Psoriasis Drugs Market
22.1. Brazil Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Psoriasis Drugs Market
23.1. Middle East Psoriasis Drugs Market Overview
23.2. Middle East Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Psoriasis Drugs Market
24.1. Africa Psoriasis Drugs Market Overview
24.2. Africa Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Psoriasis Drugs Market Competitive Landscape And Company Profiles
25.1. Psoriasis Drugs Market Competitive Landscape
25.2. Psoriasis Drugs Market Company Profiles
25.2.1. AbbVie Inc.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Pfizer Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Novartis
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Eli Lilly and Company.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Celgene Corporation
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Psoriasis Drugs Market
27. Psoriasis Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Psoriasis Drugs Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer
